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Abstract
Background Left ventricular dysfunction is an important co-
morbidity of end-stage renal disease (ESRD) and is associated
with a poor prognosis in the adult population. In pediatric
ESRD, left ventricular function is generally well preserved,
but limited information is available on early changes in myo-
cardial function. The aim of this study was to investigate
myocardial mechanics in pediatric patients with ESRD using
speckle-tracking echocardiography (STE).
Methods Echocardiographic studies, including M-mode, tis-
sue Doppler imaging (TDI) and STE, were performed in 19
children on dialysis, 17 transplant patients and 33 age-
matched controls. Strain measurements were performed from
the apical four-chamber and the short axis view, respectively.
Results The interventricular and left ventricular posterior wall
thickness was significantly increased in dialysis and transplant
patients compared to healthy controls. No significant differ-
ences were found in shortening fraction, ejection fraction and
systolic tissue Doppler velocities. Dialysis and transplant pa-
tients had a decreased mean longitudinal strain compared to
healthy controls, with a mean difference of 3.1 [95 % confi-
dence interval (CI) 2.0–4.4] and 2.7 (95 % CI 1.2–4.2), re-
spectively. No differences were found for radial and circum-
ferential strain.
Conclusions Speckle-tracking echocardiography may reveal
early myocardial dysfunction in the absence of systolic dys-
function measured by conventional ultrasound or TDI in chil-
dren with ESRD.
Keywords Cardiovascular Imaging . Pediatric . Systolic
dysfunction . Longitudinal strain . Children
Introduction
Cardiovascular disease is highly prevalent in children and
adults with end-stage renal disease (ESRD) and has been
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shown to be one of the main causes of mortality [1–4]. In
young adults with ESRD, left ventricular hypertrophy (LVH)
and impaired systolic function are found even at early stages
of chronic kidney disease (CKD) [5–10]. In children with
ESRD, systolic LV function generally seems to be well pre-
served, as described in observational studies using two-
dimensional (2D) echocardiography and tissue Doppler mea-
surements [7, 11].
Newer echocardiographic techniques, such as speckle-
tracking echocardiography (STE), allow the study of myocar-
dial deformation and myocardial mechanics [12–14]. STE has
been used to describe early changes in myocardial mechanics
prior to changes in the ejection fraction (EF). Studies in adults
and children exposed to anthracyclines have shown that
changes in longitudinal strain can be observed prior to chang-
es in EF [15–17]. The same has been described in children
with Duchenne cardiomyopathy [18]. In adults with CKD, a
deterioration in renal function (estimated glomerular filtration
rate) has been shown to be associated with a decline in strain
values [19, 20], while in adults with ESRD, a decreased lon-
gitudinal strain has been shown to be a significant risk factor
for all-cause mortality [21]. The aim of the study reported here
was to identify early changes in myocardial mechanics in




This is a multicenter prospective cohort study which recruited
patients, aged 0–19 years, in three academic medical centers
(AMC) in the Netherland (Emma Children’s Hospital AMC
Amsterdam, Radboud University AMC and University
Medical Center Utrecht) between 1 October 2007 and 1
April 2015. Children with a congenital heart disease were
excluded. These three centers are involved in the Renal
Insufficiency therapy in Children–Quality assessment and im-
provement (RICH-Q) project, in which all Dutch and Belgian
centers providing pediatric renal replacement therapy (RRT)
collaborate to improve the quality of care [22].
Controls were selected from a database of healthy Dutch
children without any medical history who had been evaluated
at the cardiology department of the respective AMC for a
benign murmur, a positive family history of structural cardiac
abnormalities or miscellaneous complaints that proved to be
non-cardiac. The groups were matched for age. We assessed
prevalence of hypertension in the patients, with hypertension
defined as a blood pressure (BP) measurement of >95th per-
centile on at least three occasions based on gender, age and
height according to the Fourth Report on the Diagnosis,
Evaluation, and treatment of High Blood Pressure in
Children and Adolescents [23], irrespective of use of antihy-
pertensives. The body mass index Z-score was calculated
based on gender and age according to the 2000 Centers for
Disease Control and Prevention growth charts [24].
Echocardiographic measurements
Echocardiographic assessment in patients undergoing hemo-
dialysis (HD) was performed after a HD session.
All children were studied using the Vivid 7 ultrasound sys-
tem (GE Medical Systems, GE Healthcare Life Sciences,
Pittsburgh, PA) using a standardized protocol. Measurements
of LV size and function were performed according to the
guidelines published by the American Society of
Echocardiography [25]. M-mode echocardiography was per-
formed from the parasternal long axis views. Assessment of
LV dimensions included: end-diastolic interventricular sep-
tum thickness (IVSd), LVend-diastolic and end-systolic diam-
eter (LVEDd and LVED, respectively) and diastolic LV pos-
terior wall thickness (LVPWd). The shortening fraction (SF)
(%) was calculated. The LV mass index (LVMI) was calculat-
ed according to the Devereux formula, including a correction
for height indexed to the power of 2.7 [26]. LVH was defined
as an LVMI (g/m2.7) of >95th percentile according to the nor-
mal values for age and gender published by Khoury et al. [26].
Early and late mitral valve inflow velocities (E and A, respec-
tively) were measured from the apical four-chamber view and
the E/A ratio calculated. Each variable was measured three
times, and the mean was calculated. Pulsed-wave tissue
Doppler imaging (TDI) images were obtained from the apical
four-chamber view. Tissue Doppler tracings were measured in
the basal interventricular septum (IVS) and the basal LV lat-
eral wall. Peak systolic (s′) and early diastolic (e′) velocities
were measured in three consecutive cycles and averaged for
both IVS (IVS s′) and basal LV wall (LV s′). Septal E/e′ and
mitral E/e′ ratios were calculated. The ejection fraction (EF)
was measured from the two-chamber and four-chamber views
using the biplane Simpson’s method.
2D grayscale images were acquired in the parasternal
apical four-chamber view at a frame rate of between 70
and 90 frames per second [27]. Three consecutive cardiac
cycles were acquired. Off-line analysis was performed
using the EchoPac workstation (GE Medical Systems).
Briefly, the endocardial border was manually traced at
end systole (starting at mid-septum for the short axis and
at the basal septum from the apical four-chamber view).
Tracking was automatically performed, and the analysis
was accepted after visual inspection and when the soft-
ware indicated adequate tracking. If tracking was sub-
optimal the endocardial border was retraced. Lagrangian
radial ε and strain rate (SR) curves and circumferential ε
curves from the short-axis view (6 segments: anterior sep-
tum, anterior, lateral, posterior, inferior and septum) and
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longitudinal ε curves from the apical four-chamber view
(6 segments: basal septum, mid septum, apical septum,
apical lateral, mid lateral and basal lateral) were obtained.
The automated timing of aortic valve closure was used,
and end-systolic strain values were measured. Mean longi-
tudinal strain (LS), radial strain (RS) and circumferential
strain (CS) were obtained by calculating the average strain
values measured in each myocardial region (Fig. 1). LS is
a negative value and thus represents shortening. A less
negative, i.e. a ‘higher’ value, indicates less shortening,
indicative of worse systolic LV function.
To assess the intra-observer variability of the STE
measurements, the same observer—blinded to the
groups—re-analyzed 25 echocardiograms, ten from
ESRD patients and 15 from healthy controls, after a
period of at least 2 weeks.
Fig. 1 Two-dimensional speckle-tracking echocardiography (STE) for
left ventricular (LV) longitudinal strain (LS) in a healthy control subject
(a) and a child with end-stage renal disease (ESRD) (b). The mean LS
(white dotted line) is the mean of the six segments of the myocardium of
the left ventricle, (e.g. yellow basal septum, light bluemid septum,
green apical septum, red basal lateral, dark blue mid lateral,
purple apical lateral). The mean LS can be seen to be significantly
lower in the child with ESRD (b) than in the healthy control subject (a)
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Statistical analysis
All analyses were performed using SPSS ver. 22.0 for
Windows statistical software (IBM Corp., Armonk, NY).
Values are presented as mean± standard deviation unless stat-
ed otherwise. An independent samples t test or Mann–
Whitney test was used to compare the means of continuous
variables when appropriate. Categorical values were com-
pared using the chi-square test or Fisher exact test, where
indicated. To assess intra-observer reproducibility, we calcu-
lated the coefficient of variation (CV) as the ratio of the stan-
dard deviation of the differences of the repeatedmeasurements
and the mean of all measurements in all individuals (grand
mean). The CV gives an indication of the measurement error
as a percentage of the mean value in the study population.
Parameters related to systolic function were compared be-
tween the ESRD and the control group using multiple linear
regression analysis to adjust for confounding. Potential con-
founders were age, gender and body surface area (BSA). If the
regression coefficient of the central determinant ‘ESRD’
changed by >10 % after the addition of a particular variable
to the regression model, this variable was considered to be a
confounder and kept in the final model. Patients on dialysis
and transplantation therapy were compared in order to assess
the influence of RRT modality. Linear regression was used to
analyze the association between total duration on RRT and
echocardiographic measurements.
Results
Measurements obtained in 36 children with ESRD and 33
healthy control subjects were analyzed. At the time of the
echocardiography, 19 children were on dialysis (15 on HD
and 4 on peritoneal dialysis) and 17 were transplant recipients.
Of the 17 transplant recipients, 11 (65 %) had been on dialysis
before this study. The median time on RRT at the time of the
echocardiography was 1.4 (range 0.0–15.6) and 2.7 (range
0.1–4.8) years for the patients on dialysis and renal transplant
recipients, respectively. The median time between transplan-
tation and echocardiography was 13 (range 0.3–40) months.
Eight (42%) patients on dialysis and six patients (35%)with a
renal transplant were diagnosed with arterial hypertension.
The characteristics of the children on dialysis, the transplant
recipients and the healthy controls are shown in Table 1.
Diastolic function
The E/A ratio did not differ significantly between the patients
and healthy controls. TDI measurements were available in 16
children on dialysis, 15 transplant recipients and 27 healthy
controls (Table 2). After adjustment for BSA, both children on
dialysis and transplant recipients had significantly lower e′
values in the IVS and LV lateral basal segments, resulting in
increased E/e′ ratios in both segments which did not, however,
reach statistical significance.
Systolic function
Systolic function in the patients, as measured with TDI (IVS s′
and LVS s′), did not differ significantly from that of the
healthy controls (Table 2).
Table 3 summarizes the results of the LV dimensions, LV
SF and LVmass. There was no difference in SF or EF between
the patients and controls. After adjustment for BSA and age,
there was a significant effect of dialysis and transplant status
on LVMI, which was increased in children on dialysis and
transplanted children compared to healthy controls. LVH
was diagnosed in 4 (21 %) of the dialysis children and 4
(24 %) of the transplant recipients.
Speckle-tracking echocardiography
There were no significant differences between the repeated
measurements: the CV of LS was 3 %, and the mean differ-
ence between measurements was 0.2 [95 % confidence inter-
val (CI) −1.5 to 1.9]. Table 4 summarizes the longitudinal,
radial and circumferential strain measurements. The mean
LS was significantly reduced in patients on dialysis and after
renal transplant when compared with the controls, with a
mean difference between the dialysis and transplantation
groups versus controls of 3.1 [95 % CI 2.0–4.4] and 2.7 [95
% CI 1.2–4.2] respectively (both P <0.001). The RS and CS
measurements did not differ significantly between the patient
groups and the controls, with a mean difference between the
RS in the dialysis and transplantation groups versus controls
of 0.5 [95 % CI −8.2 to 7.1] and 5.0 [95 % CI −2.6 to12.6],
respectively. The mean difference between the CS in the dial-
ysis and transplantation groups versus the controls was 0.5 [95
% −1.7 to 2.8] and 0.5 [95 % −1.9 to 2.9], respectively. LS
decreased with 0.05 per unit increase of LVMI, but it did not
differ between patients with and patients without LVH (mean
difference of −1.0 [−3.4 to 1.5].
Influence of RRT and presence of hypertension
There were no significant differences between the renal trans-
plant and the dialysis groups with respect to conventional
echocardiographic measurements, TDI or STE measurements
(Tables 2, 3, 4). No significant association was found between
total duration of RRT and the echocardiographic parameters.
LS and LVMI did not differ between patients with and without
hypertension. The mean difference in LS and LVMI for pa-
tients with and without hypertension was 1.1 [95 % CI −2.4 to
1.9] and 4.2 [−7.3 to 9.9], respectively.
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Discussion
Our study demonstrates that in pediatric patients with ESRD,
longitudinal LV strain was significantly lower in both dialysis
and renal graft recipients compared with normal controls,
while radial and circumferential function were not different.
Also, SF and EF were generally normal. These findings sug-
gest that in children with ESRD, LV systolic performance
assessed by EF is generally normal, whereas STE detects
changes in longitudinal deformation and diastolic function.
In hypertensive patients, diastolic dysfunction precedes
systolic function [28], and this has been described previously
in pediatric ESRD [10, 29, 30]. We found decreased e′-veloc-
ities, suggestive of reduced early relaxation and increased E/e′
ratio which could indicate higher filling pressures in the pa-
tients. The increased filling pressures could be related to vol-
ume status or represent reduced LV compliance and may be
caused by uremic toxins inducing an inflammatory response
or be related to the maladaptive hypertrophic response in this
patient population group [31]. Thse hypotheses need further
study by cardiac magnetic resonance imaging or other imag-
ing modalities.
In ESRD, hypertension and uremic factors are indepen-
dently associated with both LVH and ventricular dysfunction
[32]. Hypertension in non-uremic patients can either lead to
concentric hypertrophy with normal or even increased EF in
early stages or to eccentric hypertrophy [33]. Apparent systol-
ic dysfunction occurs only in advanced stages of
hypertension-induced LVH. In adult ESRD patients, however,
systolic dysfunction may occur at a relative early stage, most
likely as a result of myocardial fibrosis induced by chronic
inflammation or in direct response to uremic toxins. This
fibrosis is an important trigger of electric myocardial instabil-
ity and hence arrhythmia [32]. In addition, endothelial dys-
function, another hallmark of ESRD, may lead to an inade-
quate vasodilatory response in the thickened left ventricle and
subsequently local ischemia, hereby further enhancing fibro-
sis [34]. Consequently, the absence of systolic dysfunction
based on EF assessment may result in an underestimation of
the existence of important systolic myocardial changes by the
uremic milieu.
In our patients, although there was an increased LVMI and
hence ventricular hypertrophy, no systolic dysfunction was
found with conventional echocardiography (normal SF and
EF) and with TDI (IVS s′ and LVS s′). Nevertheless, STE
showed a decreased LS in our patients, suggesting that longi-
tudinal function is reduced in the patient group, while radial
and circumferential function is preserved. LV concentric hy-
pertrophy is mainly caused by hypertrophic response in the
mid-myocard ia l layers , which are main ly more
circumferentially oriented. This compensates for the reduction
in longitudinal function and can explain the preserved EF.
Changes in longitudinal function with preserved EF have been
described in other disease populations, mainly in patients with
LVH [35]. Hothi et al. [36] described a decreased LS in chil-
dren on dialysis with preservation of global function.
Our findings are consistent with data obtained in hyperten-
sive adults as reported by Imbalzano et al. [37]. In patients
with hypertension, the changes are most prominent in the
basal part of the IVS. A decrease in longitudinal function
precedes changes in circumferential and radial function in
patients with LVH due to pressure overload, whereas in hy-
pertrophic cardiomyopathy or systemic disease, not only lon-
gitudinal, but also radial strain can be impaired [35]. In our
Table 1 General characteristics of the study population
General characteristics Study population P value










Male 12 (63 %) 12 (70 %) 16 (49 %) 0.78a 0.08a 0.45a
Hypertension 8 (42 %) 6 (35 %) 0 (0 %) <0.001a 0.001a 0.74a
RRT duration (years) 1.4 [0.0–15.6] 2.7 [0.1–4.8] - - - 0.30b
GFR (ml/min/1.73 m2) 7.9 [4.0–27.0] 60.3 [7.2–95.7] - - - -
Hemoglobin (mmol/l) 6.7 [5.3–8.0] 7.2 [5.4–8.5] - - - 0.07
BSA (m2) 1.3 ± 0.4 1.3 ± 0.4 1.4 ± 0.4 0.67b 0.63b 0.85b
BMI Z-score -0.1 [−3.1 to 1.6] 0.7 [−1.0 to 2.6] 0.2 [−3.8 to 1.7] 0.12b 0.21b 0.03b
Age (years) 15.1 [1.2–17.9] 13.7 [4.6–18.4] 12.5 [2.4–18.3] 0.24b 0.47b 0.89b
Values in table are presented as the median with the range in square brackets, a number (n) with the percentage in parenthesis or the mean ± standard
deviation (SD)
RRT renal replacement therapy,GFR glomerular filtration rate (calculated according to the 2009 Schwartz formula), BSA body surface area (according to
the Dubois and Dubois formula), BMI body mass index
a Fisher's exact test
b Mann-Whitney U test
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study, LV mass increased in 21 % of the dialysis patients and
24 % of the renal transplant patients, suggesting some degree
of LVH, but the presence of LVH did not seem to be a risk
factor for the decrease in LS, in turn suggesting that the chang-
es in strain can be present in ESRD patients in the absence of
LVH. However, it should be noted that the measurement of
LVH in pediatric ESRD has already been shown to be less
reliable, as demonstrated by Schoenmaker et al. [38].
In ESRD, volume overload and myocardial ischemia in-
duced by HD can cause mechanical dyssynchrony by imbal-
ances in the stretching and shortening of myocardial fibers,
which results in a pathological STE pattern that may affect
systolic function [39, 40]. Cardiac fibrosis is highly prevalent
in patients with ESRD, but the origin and mechanisms of
fibrosis in the heart are have not yet been completely elucidat-
ed [41–43]. In addition, in patients with CKD, myocardial
dysfunction is not merely the result of cardiac remodeling;
especially in dialysis patients, impaired myocardial reserve
may induce recurrent myocardial stunning and hence myocar-
dial dysfunction. In ESRD, high serum phosphate levels, high
fibroblast growth factor 23 (FGF23) levels and low serum
Klotho levels are considered to play a role in cardiac hyper-
trophy and cardiac fibrosis. High serum FGF23 levels are
primarily associated with LVH, whereas low serum Klotho
levels and hyperphosphatemia are associated with endothelial
dysfunction, atherosclerosis and fibrosis [41, 44]. It is possible
that high serum phosphate levels and low serum Klotho levels
may independently of high FGF23 levels induce cardiac fibro-
sis, resulting in dyssynchronous myocardial function.
However, this hypothesis is not supported by our data.
As previously described, changes in longitudinal myocar-
dial function with preserved EF have been described in other
disease populations, as well as in adult ESRD patients [15, 16,
20, 45–47]. In a recent systematic review and meta-analysis in
adults (mean age >60 years), global LS was considered to
have a superior prognostic value to EF for predicting major
adverse cardiac events [45]. Furthermore, LS has been shown
to be significantly associated with all-cause mortality in adults
with chronic ischemic cardiomyopathy [hazard ratio 1.69 (95
% CI 1.33–2.15) per 5 % increase; p <0.001] [48]. Whether a
reduction in LS can be used as a specific predictor of cardio-
vascular morbidity and mortality in children with ESRD re-
mains to be established. This will require longitudinal follow-
up studies in children with ESRD.
We found no significant differences in echocardiography
measurements between children on dialysis and those on a
functioning graft, nor did we find significant associations be-
tween duration on RRTand echocardiographic measurements.
This suggests that duration of dialysis does not influence car-
diac performance. However, we were unable to draw conclu-
sions from our analysis of the association between dialysis
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Limitations
The major limitation of this study is the small sample size. The
study was limited to the three hospitals in the RICH-Q project
where the same ultrasound equipment was used, as we wanted
to avoid the effect of inter-machine variability on the measure-
ments. Machines of different vendors produce different values
for speckle-tracking strain-derived parameters [49] and, conse-
quently, comparison is more difficult. Despite adopting a pro-
spective protocol, we were unable to acquire all data prospec-
tively from all patients because some images were of poor
quality, limiting the number of available scans. Adjustment of
echocardiographic measurements to body size in our popula-
tion was challenging as many ESRD patients had a shorter
height and smaller BSA compared to age-matched controls.
We were not able to assess inter-observer variability; however
a recent study has shown a good reproducibility of strain mea-
surements with low inter- and intra-observer relative mean er-
rors, with lower errors than for EF and most other conventional
echocardiographic parameters [50].
Conclusion
We found a decreased LS, suggestive of systolic dysfunction in
pediatric ESRD patients, while systolic function measured both
by conventional echocardiography and TDI was preserved. STE
may reveal early myocardial dysfunction in the absence of sys-
tolic dysfunction in ESRDchildren. The long-term importance of
these findings warrants further investigation and follow-up.













P value Mean difference
[95 % CI]
P value Mean difference
[95 % CI]
P value
Longitudinal strain (%) n = 19 n = 17 n = 33
Basal septum −15.2 ± 3.4 −16.8 ± 2.6 −15.4 ± 2.5
Mid septum −18.9 ± 2.4 −19.5 ± 1.9 −20.1 ± 1.8
Apical septum −20.2 ± 5.3 −19.6 ± 4.5 −23.0 ± 4.0
Basal lateral −17.0 ± 5.0 −15.2 ± 5.4 −18.8 ± 5.6
Mid lateral −15.0 ± 5.4 −15.2 ± 6.0 −19.8 ± 3.3
Apical lateral −17.0 ± 5.1 −16.8 ± 7.5 20.6 ± 4.9
Mean Longitudinal
strain
−16.6 ± 2.8 −16.7 ± 3.4 −19.4 ± 2.1 3.1 [2.0–4.4] <0.001 2.7 [1.2–4.2] 0.001 0.4 [−1.7 to 2.5] 0.68
Radial strain (%) n= 16 n= 17 n= 33
Basal septum 18.0 ± 9.8 25.1 ± 14.6 22.6 ± 10.7
Mid septum 19.8 ± 13.9 20.4 ± 13.2 17.9 ± 15.7
Apical septum 27.1 ± 21.0 26.9 ± 16.7 19.1 ± 19.5
Basal lateral 14.6 ± 12.1 21.3 ± 21.7 17.9 ± 10.5
Mid lateral 28.5 ± 21.2 29.6 ± 18.8 24.1 ± 13.8
Apical lateral 37.5 ± 29.3 35.7 ± 18.1 30.6 ± 23.8
Mean radial strain 24.3 (14.5) 26.5 ± 13.3 22.0 ± 12 0.5 [−8.2 to 7.1] 0.88 5.0 [−2.6 to 12.6] 0.19 4.6 [−4.5 to 13.7] 0.31
Circumferential
strain (%)
n = 16 n= 15 n= 33
Basal septum 21.0 ± 6.8 24.2 ± 5.3 21.2 ± 5.2
Mid septum 15.7 ± 5.9 21.5 ± 7.3 17.5 ± 6.0
Apical septum 13.7 ± 6.0 15.5 ± 5.4 15.5 ± 4.9
Basal lateral 21.3 ± 5.0 21.2 ± 4.4 21.8 ± 3.9
Mid lateral 17.0 ± 5.9 16.2 ± 5.0 16.8 ± 6.3
Apical lateral 15.2 ± 7.7 12.5 ± 6.1 14.5 ± 6.5
Mean
circumferential strain
17.3 ± 3.4 17.9 ± 4.1 17.4 ± 4.0 0.5 [−1.7 to 2.8] 0.65 0.5 [−1.9 to 2.9] 0.66 1.0 [−1.7 to 3.6] 0.45
Data in table are presented as the mean ± SD, unless indicated otherwise
CI confidence interval
a All groups were compared using multiple linear regression analysis to adjust for confounding by body surface area (BSA)
1506 Pediatr Nephrol (2016) 31:1499–1508
Acknowledgments This study was performed as part of the RICH-Q
project, which is mainly funded by the Dutch Kidney Foundation.
Additional funding was provided by Astellas, Ferring Pharmaceuticals,
Sanofi, Roche and Shire. The funders had no role in the design and
conduct of the project, data gathering or interpretation, or in the prepara-
tion of the manuscript. We are grateful to all patients and the participating
centers in the RICH-Q study. We kindly thank Prof. Dr. Laura Bennet for
her comments on the earlier version of this manuscript.
Compliance with ethical standards The research ethics boards of all
participating hospitals approved the study. Written informed consent was
obtained from the parents and/or the patients.
Financial disclosure None.
Conflict of interest All authors declare that they have no conflicts of
interest regarding this work.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
References
1. Groothoff J, Gruppen M, de Groot E, Offringa M (2005)
Cardiovascular disease as a late complication of end-stage renal
disease in children. Perit Dial Int 25[Suppl 3]:S123–126
2. Groothoff JW (2005) Long-term outcomes of children with end-
stage renal disease. Pediatr Nephrol 20:849–853
3. GruppenMP, Groothoff JW, PrinsM, van derWouw P, OffringaM,
Bos WJ, Davin JC, Heymans HS (2003) Cardiac disease in young
adult patients with end-stage renal disease since childhood: a Dutch
cohort study. Kidney Int 63:1058–1065
4. McDonald SP, Craig JC (2004) Long-term survival of children with
end-stage renal disease. N Engl J Med 350:2654–2662
5. Chinali M, de Simone G,Matteucci MC, Picca S, Mastrostefano A,
Anarat A, Caliskan S, Jeck N, Neuhaus TJ, Peco-Antic A, Peruzzi
L, Testa S, Mehls O, Wuhl E, Schaefer F (2007) Reduced systolic
myocardial function in children with chronic renal insufficiency. J
Am Soc Nephrol 18:593–598
6. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray
DC, Barre PE (1995) Clinical and echocardiographic disease in
patients starting end-stage renal disease therapy. Kidney Int 47:
186–192
7. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG,
Powell HR (1996) Left ventricular abnormalities in children, ado-
lescents and young adults with renal disease. Kidney Int 50:998–
1006
8. Matteucci MC, Wuhl E, Picca S, Mastrostefano A, Rinelli G,
Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F (2006)
Left ventricular geometry in children with mild to moderate chronic
renal insufficiency. J Am Soc Nephrol 17:218–226
9. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ,
Khoury PR, Daniels SR (2004) Impaired left ventricular diastolic
function in children with chronic renal failure. Kidney Int 65:1461–
1466
10. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ,
Khoury PR, Daniels SR (2006) Progression of left ventricular
hypertrophy in children with early chronic kidney disease: 2-year
follow-up study. J Pediatr 149:671–675
11. Palcoux JB, Palcoux MC, Jouan JP, Gourgand JM, Cassagnes J,
Malpuech G (1982) Echocardiographic patterns in infants and chil-
dren with chronic renal failure. Int J Pediatr Nephrol 3:311–314
12. Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J,
Lyseggen E, Stoylen A, Ihlen H, Lima JA, Smiseth OA, Slordahl
SA (2006) Noninvasive myocardial strain measurement by speckle
tracking echocardiography: validation against sonomicrometry and
tagged magnetic resonance imaging. J Am Coll Cardiol 47:789–
793
13. Bohs LN, Trahey GE (1991) A novel method for angle independent
ultrasonic imaging of blood flow and tissue motion. IEEE Trans
Biomed Eng 38:280–286
14. Mondillo S, Galderisi M, Mele D, Cameli M, Lomoriello VS, Zaca
V, Ballo P, D'Andrea A,Muraru D, Losi M, Agricola E, D'Errico A,
Buralli S, Sciomer S, Nistri S, Badano L (2011) Speckle-tracking
echocardiography: a new technique for assessing myocardial func-
tion. J Ultrasound Med 30:71–83
15. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang
T, Tian G, Kirkpatrick ID, Singal PK, Krahn M, Grenier D, Jassal
DS (2011) The utility of cardiac biomarkers, tissue velocity and
strain imaging, and cardiac magnetic resonance imaging in
predicting early left ventricular dysfunction in patients with human
epidermal growth factor receptor II-positive breast cancer treated
with adjuvant trastuzumab therapy. J Am Coll Cardiol 57:2263–
2270
16. Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW (2012)
Changes in left ventricular longitudinal strain with anthracycline
chemotherapy in adolescents precede subsequent decreased left
ventricular ejection fraction. J Am Soc Echocardiogr 25:733–740
17. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, Gosavi
S, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE,
Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M (2011) Early
detection and prediction of cardiotoxicity in chemotherapy-treated
patients. Am J Cardiol 107:1375–1380
18. Mertens L, Ganame J, Claus P, Goemans N, Thijs D, Eyskens B,
Van Laere D, Bijnens B, D'Hooge J, Sutherland GR, Buyse G
(2008) Early regional myocardial dysfunction in young patients
with Duchenne muscular dystrophy. J Am Soc Echocardiogr 21:
1049–1054
19. Liu YW, Su CT, Huang YY, Yang CS, Huang JW, Yang MT, Chen
JH, Tsai WC (2011) Left ventricular systolic strain in chronic kid-
ney disease and hemodialysis patients. Am J Nephrol 33:84–90
20. Yan P, Li H, Hao C, Shi H, Gu Y, Huang G, Chen J (2011) 2D-
speckle tracking echocardiography contributes to early identifica-
tion of impaired left ventricular myocardial function in patients with
chronic kidney disease. Nephron Clin Pract 118:c232–c240
21. Kramann R, Erpenbeck J, Schneider RK, Rohl AB, Hein M,
Brandenburg VM, van Diepen M, Dekker F, Marx N, Floege J,
Becker M, Schlieper G (2014) Speckle tracking echocardiography
detects uremic cardiomyopathy early and predicts cardiovascular
mortality in ESRD. J Am Soc Nephrol 25:2351–2365
22. Renal Insufficiency therapy in Children–Quality assessment and
improvement (RICH-Q) study. Available at: [https://www.rich-q.nl]
23. National High Blood Pressure Education Program Working Group
on High Blood Pressure in Children and Adolescents (2004) The
fourth report on the diagnosis, evaluation, and treatment of high
blood pressure in children and adolescents. Pediatrics 114[2 Suppl
4th Report]:555-576
24. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal
KM,Mei Z,Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000
CDC Growth Charts for the United States: methods and develop-
ment. Vital Health Stat 11:1–190
25. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook
MM, Pignatelli RH, Rychik J, Task Force of the Pediatric Council
Pediatr Nephrol (2016) 31:1499–1508 1507
of the American Society of Echocardiography, Pediatric Council of
the American Society of Echocardiography (2006) Guidelines and
standards for performance of a pediatric echocardiogram: a report
from the Task Force of the Pediatric Council of the American
Society of Echocardiography. J Am Soc Echocardiogr 19:1413–
1430
26. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-
specific reference intervals for indexed left ventricular mass in chil-
dren. J Am Soc Echocardiogr 22:709–714
27. Korinek J, Wang J, Sengupta PP, Miyazaki C, Kjaergaard J,
McMahon E, Abraham TP, Belohlavek M (2005) Two-
dimensional strain–a Doppler-independent ultrasound method for
quantitation of regional deformation: validation in vitro and in vivo.
J Am Soc Echocardiogr 18:1247–1253
28. Slama M, Susic D, Varagic J, Frohlich ED (2002) Diastolic dys-
function in hypertension. Curr Opin Cardiol 17:368–373
29. Schoenmaker NJ, Kuipers IM, van der Lee JH, Tromp WF, van
Dyck M, Gewillig M, Blom NA, Groothoff JW (2014) Diastolic
dysfunction measured by tissue Doppler imaging in children with
end-stage renal disease: a report of the RICH-Q study. Cardiol
Young 24:236–244
30. Ten Harkel AD, Cransberg K, Van Osch-Gevers M, Nauta J (2009)
Diastolic dysfunction in paediatric patients on peritoneal dialysis and
after renal transplantation. Nephrol Dial Transplant 24:1987–1991
31. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G,
Cataliotti A, Seminara G, Stancanelli B, Malatino LS (2001)
Prognostic impact of the indexation of left ventricular mass in pa-
tients undergoing dialysis. J Am Soc Nephrol 12:2768–2774
32. Scharer K, Schmidt KG, Soergel M (1999) Cardiac function and
structure in patients with chronic renal failure. Pediatr Nephrol 13:
951–965
33. Santos M, Shah AM (2014) Alterations in cardiac structure and
function in hypertension. Curr Hypertens Rep 16:428
34. Hajhosseiny R, Khavandi KF, Goldsmith DJ (2013) Cardiovascular
disease in chronic kidney disease: untying the Gordian knot. Int J
Clin Pract 67:14–31
35. CikesM, SutherlandGR, Anderson LJ, Bijnens BH (2010) The role
of echocardiographic deformation imaging in hypertrophic myopa-
thies. Nat Rev Cardiol 7:384–396
36. Hothi DK, Rees L, McIntyre CW, Marek J (2013) Hemodialysis-
induced acute myocardial dyssynchronous impairment in children.
Nephron Clin Pract 123:83–92
37. Imbalzano E, Zito C, Carerj S, Oreto G, Mandraffino G, Cusmà-
Piccione M, Di Bella G, Saitta C, Saitta A (2011) A Left ventricular
function in hypertension: new insight by speckle tracking echocar-
diography. Echocardiography 28:649–657
38. Schoenmaker NJ, van der Lee JH, Groothoff JW, van Iperen GG,
Frohn-Mulder IM, Tanke RB, Ottenkamp J, Kuipers IM (2013)
Low agreement between cardiologists diagnosing left ventricular
hypertrophy in children with end-stage renal disease. BMC
Nephrol 14:170
39. Lagies R, Beck BB, Hoppe B, Sheta SS, Weiss V, Sreeram N,
Udink Ten Cate FE (2015) Inhomogeneous longitudinal cardiac
rotation and impaired left ventricular longitudinal strain in children
and young adults with end-stage renal failure undergoing hemodi-
alysis. Echocardiography 32:1250–1260
40. Murata T, Dohi K, Onishi K, Sugiura E, Fujimoto N, Ichikawa K,
Ishikawa E, Nakamura M, Nomura S, Takeuchi H, Nobori T, Ito M
(2011) Role of haemodialytic therapy on left ventricular mechanical
dyssynchrony in patients with end-stage renal disease quantified by
speckle-tracking strain imaging. Nephrol Dial Transplant 26:1655–
1661
41. Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, Shelton J,
Amaral AP, Faul C, Taniguchi M,Wolf M, BrandM, Takahashi M,
Kuro OM, Hill JA, Moe OW (2015) Klotho and phosphate are
modulators of pathologic uremic cardiac remodeling. J Am Soc
Nephrol 26:1290–1302
42. Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE (2009)
Serum intact FGF23 associate with left ventricular mass, hypertro-
phy and geometry in an elderly population. Atherosclerosis 207:
546–551
43. Przybylowski P, Wasilewski G, Janik L, Kozlowska S, Nowak E,
Malyszko J (2014) Fibroblast growth factor 23 and Klotho as car-
diovascular risk factors in heart transplant recipients. Transplant
Proc 46:2848–2851
44. Scialla JJ, Wolf M (2014) Roles of phosphate and fibroblast growth
factor 23 in cardiovascular disease. Nat Rev Nephrol 10:268–278
45. Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of
global LV dysfunction: a systematic review and meta-analysis of
global longitudinal strain and ejection fraction. Heart 100:1673–
1680
46. Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL,
Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY
(2008) Association between regional ventricular function and myo-
cardial fibrosis in hypertrophic cardiomyopathy assessed by speck-
le tracking echocardiography and delayed hyperenhancement mag-
netic resonance imaging. J Am Soc Echocardiogr 21:1299–1305
47. Wang H, Liu J, Yao XD, Li J, Yang Y, Cao TS, Yang B (2012)
Multidirectional myocardial systolic function in hemodialysis pa-
tients with preserved left ventricular ejection fraction and different
left ventricular geometry. Nephrol Dial Transplant 27:4422–4429
48. Bertini M, Ng AC, Antoni ML, Nucifora G, Ewe SH, Auger D,
Marsan NA, Schalij MJ, Bax JJ, Delgado V (2012) Global longitu-
dinal strain predicts long-term survival in patients with chronic
ischemic cardiomyopathy. Circ Cardiovasc Imaging 5:383–391
49. Koopman LP, Slorach C, Hui W, Manlhiot C, McCrindle BW,
Friedberg MK, Jaeggi ET, Mertens L (2010) Comparison between
different speckle tracking and color tissue Doppler techniques to
measure global and regional myocardial deformation in children. J
Am Soc Echocardiogr 23:919–928
50. Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP,
Voigt JU (2015) Head-to-head comparison of global longitudinal
strain measurements among nine different vendors: The EACVI/
ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr 28:
1171–1181
1508 Pediatr Nephrol (2016) 31:1499–1508
